Deoxyribonuclease I footprinting reveals different DNA binding modes of bifunctional platinum complexes

被引:10
作者
Chvalova, Katerina
Kasparkova, Jana
Farrell, Nicholas
Brabec, Viktor
机构
[1] Acad Sci Czech Republ, Inst Biophys, CZ-61265 Brno, Czech Republic
[2] Virginia Commonwealth Univ, Dept Chem, Richmond, VA 23284 USA
关键词
cross-link; conformation; DNA; DNase I; footprinting; platinum complex;
D O I
10.1111/j.1742-4658.2006.05356.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Deoxyribonuclease I (DNase I) footprinting methodology was used to analyze oligodeoxyribonucleotide duplexes containing unique and single, site-specific adducts of trinuclear bifunctional platinum compound, [{trans-PtCl(NH3)(2)}(2)mu-trans-Pt(NH3)(2){H2N(CH2)(6)NH2}(2)](4+) (BBR3464) and the results were compared with DNase I footprints of some adducts of conventional mononuclear cis-diamminedichloroplatinum(II) (cisplatin). These examinations took into account the fact that the local conformation of the DNA at the sites of the contacts of DNase I with DNA phosphates, such as the minor groove width and depth, sequence-dependent flexibility and bendability of the double helix, are important determinants of sequence-dependent binding to and cutting of DNA by DNase I. It was shown that various conformational perturbations induced by platinum binding in the major groove translated into the minor groove, allowing their detection by DNase I probing. The results also demonstrate the very high sensitivity of DNase I to DNA conformational alterations induced by platinum complexes so that the platinum adducts which induce specific local conformational alterations in DNA are differently recognized by DNase I.
引用
收藏
页码:3467 / 3478
页数:12
相关论文
共 36 条
[1]   Heterogeneity in the actions of drugs that bind in the DNA minor groove [J].
Albert, FG ;
Eckdahl, TT ;
Fitzgerald, DJ ;
Anderson, JN .
BIOCHEMISTRY, 1999, 38 (31) :10135-10146
[2]   DISTORTIONS INDUCED IN DOUBLE-STRANDED OLIGONUCLEOTIDES BY THE BINDING OF CIS-DIAMMINE-DICHLOROPLATINUM(II) OR TRANS-DIAMMINE-DICHLOROPLATINUM(II) TO THE D(GTG) SEQUENCE [J].
ANIN, MF ;
LENG, M .
NUCLEIC ACIDS RESEARCH, 1990, 18 (15) :4395-4400
[3]  
[Anonymous], MET COMPD CANC CHEMO
[4]  
Bailly C, 1999, ANTI-CANCER DRUG DES, V14, P291
[5]   DNA recognition by quinoline antibiotics: Use of base-modified DNA molecules to investigate determinants of sequence-specific binding of luzopeptin. [J].
Bailly, C ;
Crow, S ;
Minnock, A ;
Waring, MJ .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2000, 19 (08) :1337-1353
[6]   Enantiospecific recognition of DNA sequences by a proflavine Troger base [J].
Bailly, C ;
Laine, W ;
Demeunynck, M ;
Lhomme, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (02) :681-685
[7]   DNA INTERSTRAND CROSS-LINKS OF TRANS-DIAMMINEDICHLOROPLATINUM(II) ARE PREFERENTIALLY FORMED BETWEEN GUANINE AND COMPLEMENTARY CYTOSINE RESIDUES [J].
BRABEC, V ;
LENG, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) :5345-5349
[8]  
Brabec V, 2000, CANC DRUG DISC DEV, V7, P37
[9]   DNA modifications by a novel bifunctional trinuclear platinum Phase I anticancer agent [J].
Brabec, V ;
Kaspárková, J ;
Vrána, O ;
Nováková, O ;
Cox, JW ;
Qu, Y ;
Farrell, N .
BIOCHEMISTRY, 1999, 38 (21) :6781-6790
[10]   DNA modifications by antitumor platinum and ruthenium compounds: Their recognition and repair [J].
Brabec, V .
PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 71, 2002, 71 :1-68